Get started
Author

Anne A. Kapaata

Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists
2020 · Gisele Umviligihozo, Lucy Mupfumi, et al. · Wellcome Open Research · 60
Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists
2020 · Gisele Umviligihozo, Lucy Mupfumi, et al. · Wellcome Open Research · 56
Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya
2011 · Kim C.E. Sigaloff, Kishor Mandaliya, et al. · AIDS Research and Human Retroviruses · 42
High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
2013 · Ravindra K. Gupta, Ruth L. Goodall, et al. · Clinical Infectious Diseases · 37
PDF
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
2015 · Pontiano Kaleebu, Wilford Kirungi, et al. · PLoS ONE · 27
PDF
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
2015 · Katherine A. Sutherland, Chris M. Parry, et al. · PLoS ONE · 25
PDF
Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda
2019 · J Birungi, Z Cui, et al. · HIV Medicine · 24
PDF
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda
2019 · Jonah Omooja, Maria Nannyonjo, et al. · Journal of Antimicrobial Chemotherapy · 24
PDF
HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic
2018 · Amrei von Braun, Christine Sekaggya-Wiltshire, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 18
HIV-1 Subtype Distribution Trends and Evidence of Transmission Clusters Among Incident Cases in a Rural Clinical Cohort in Southwest Uganda, 2004–2010
2012 · Anne Kapaata, Frederick Lyagoba, et al. · AIDS Research and Human Retroviruses · 15
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
2015 · Katherine A. Sutherland, Ruth L. Goodall, et al. · AIDS Research and Human Retroviruses · 14
PDF
Transmitted Antiretroviral Drug Resistance Among Drug-Naive Female Sex Workers With Recent Infection in Kampala, Uganda
2012 · Deogratius Ssemwanga, Nicaise Ndembi, et al. · Clinical Infectious Diseases · 13
Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
2022 · Sheila N. Balinda, Anne Kapaata, et al. · Viruses · 12
PDF
From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
2016 · On behalf of the CoLTART study team, Ivan Namakoola, et al. · BMC Research Notes · 12
PDF
The Molecular Epidemiology and Transmission Dynamics of HIV Type 1 in a General Population Cohort in Uganda
2020 · Deogratius Ssemwanga, Nicholas Bbosa, et al. · Viruses · 11
PDF
Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response
2021 · Ed McGowan, Rachel Rosenthal, et al. · Frontiers in Immunology · 10
PDF
Low Drug Resistance Levels Among Drug-Naive Individuals with Recent HIV Type 1 Infection in a Rural Clinical Cohort in Southwestern Uganda
2012 · Deogratius Ssemwanga, Anne Kapaata, et al. · AIDS Research and Human Retroviruses · 10
Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A
2022 · Anne Kapaata, Sheila N. Balinda, et al. · IJID Regions · 6
PDF
HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity
2021 · Anne Kapaata, Sheila N. Balinda, et al. · Viruses · 4
PDF
Subtype AD Recombinant HIV-1 Transmitted/Founder Viruses Are Less Sensitive to Type I Interferons than Subtype D
2025 · Denis Omara, Fortunate Natwijuka, et al. · Viruses · 3
BonoboFlow: viral genome assembly and haplotype reconstruction from nanopore reads
2024 · Christian Ndekezi, Drake Byamukama, et al. · Bioinformatics Advances · 3
PDF
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda
2014 · R. L. Goodall, D. T. Dunn, et al. · Journal of Antimicrobial Chemotherapy · 3
PDF
Practical guidelines for producing non-replicating canine adenovirus vectors
2026 · Denis Omara, Christian Ndekezi, et al. · PLoS ONE · 1
PDF
Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification
2025 · Drake Byamukama, Christian Ndekezi, et al. · International Journal of Infectious Diseases · 1
PDF
Limited Impact of First-Line Drug Resistance Mutations on Virologic Response Among Patients Receiving Second-Line Antiretroviral Therapy in Rural Uganda
2022 · David M. Moore, Mastula Nanfuka, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1
Works count: 32
Citation count: 433
H-index: 12
I10-index: 17
Year
Topic
Type